Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased

J Al Suwaidi1, S T Higano, D R Holmes

  • 1Center for Coronary Physiology and Imaging, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.

Insights

Obesity is linked to impaired coronary endothelial function in patients with normal or mild coronary artery disease. This finding highlights obesity as an independent risk factor for endothelial dysfunction, impacting heart health.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Obesity Medicine

Background:

  • Obesity is recognized by the American Heart Association (AHA) as a modifiable risk factor for coronary heart disease.
  • Coronary endothelial dysfunction is an early indicator of cardiovascular disease.

Purpose of the Study:

  • To evaluate the impact of obesity on coronary endothelial function.
  • To assess endothelial function in patients with normal or mild coronary artery disease across different body mass index (BMI) categories.

Main Methods:

  • 397 patients with normal or mild coronary artery disease underwent coronary vascular reactivity testing.
  • Patients were categorized into normal weight (BMI <25), overweight (BMI 25-30), and obese (BMI >30) groups.
  • Coronary blood flow response to intracoronary acetylcholine was measured.

Main Results:

  • Obese patients exhibited significantly lower coronary blood flow response to acetylcholine compared to normal-weight individuals.
  • Overweight and obesity were independently associated with impaired coronary endothelial function (OR 1.55 and 2.41, respectively).
  • No significant differences in other cardiovascular risk factors were observed between groups, except for age in overweight patients.

Conclusions:

  • Obesity is independently associated with coronary endothelial dysfunction.
  • These findings suggest that weight management is crucial for maintaining endothelial health in patients with coronary artery disease.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...